DuTOC: een grote vijver om in te vissen – Oncologie Vandaag
December, 2025
A nice article about DuTOC. To read the full article you need to login on Oncologie Vandaag.
New national platform for lung cancer research – Longkanker Nederland
November, 2025
Translated
The Dutch Thoracic Oncology Cohort (DuTOC) was recently launched. It will become a national platform for long-term research into lung cancer. DuTOC collects medical data and questionnaires from patients with all forms of lung cancer, thymus cancer and mesothelioma.
By asking patients if they want to participate in DuTOC, information is collected nationwide. In this way, we hope to gain a better understanding why someone develops lung cancer andbe able to provide even better tailored treatment, in the future. Patients who register for DuTOC may also receive an invitation if there is a study that may be of interest to them.
The project is still in its start-up phase. DuTOC was launched at the UMCU and the MUMC+ will follow soon. Registration for the project will always be done through the treating physician or hospital. Unfortunately, this means that not everyone can participate at this time.
We are working hard to launch DuTOC in other hospitals as well. We expect more hospitals to participate in the coming months.
Nieuw landelijk platform voor onderzoek longkanker | Longkanker Nederland
DuTOC: The prospective Dutch Thoracic Oncology Cohort: A nationwide infrastructure to collect clinical data, PROMS and bio-material to support thoracic oncology studies
Aug, 2025
This publication is about the DuTOC protocol and can be read here.
Abstract
“The Dutch Thoracic Oncology Cohort (DuTOC) is a nationwide cohort for patients with thoracic malignancies collecting patient characteristics, quality of life and biomaterials after informed consent of the patient. With this data and material DuTOC is a solid infrastructure for retrospective and prospective studies involving treatment, (molecular) diagnostics, quality control, biomarkers and translational research and quality of life. DuTOC is initiated by the Dutch Association of Pulmonologists and is a collaboration of all clinicians involved in cancer-care and other stakeholders in the field of thoracic malignancies such as patient advocacies, health regulatory agencies, cancer registries and pharmaceutical companies. DuTOC has the ambition to automate real-time data acquisition. This minimizes the workload of the research staff and facilitates the transition to a self-learning health care system based on real-time data, incorporating long-term longitudinal assessment of patient reported outcome measurements. Therefore, DuTOC will play a crucial role in the improvement of the care for patients with thoracic malignancies.“
Het Dutch Thoracic Oncology Cohort: “Een mooie kapstok voor allerhande substudies” – MedNet
May, 2025
A nice article written in Dutch about DuTOC, available to read on MedNet.